The differences in functional outcomes of ROCK1 deficiency in MEFs vs. leukemic cells are likely due to variations in anchorage-dependency, cytoskeleton organization and interacting partners in normal vs. tumor cells. This evidence concerns the gene ROCK1 and neoplasm.